CU Innovations continues to redefine the future of patient care through a dynamic blend of translational science, venture development, and strategic partnerships. The 2025 Annual Report highlights a year of bold initiatives and measurable impact, as CU Anschutz researchers and startup collaborators advanced therapies, reshaped clinical trial design, and accelerated commercialization across the biomedical landscape.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
